About us
We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
-
revolutionizing precision medicine
Management team
Paul van de Wiel
Chief Executive Officer
Sigi Neerken
Chief Business Officer
Eveline den Biezen
Chief Technology Officer